Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.

Source:http://linkedlifedata.com/resource/pubmed/id/20187793

Download in:

View as

General Info

PMID
20187793